SII cervical cancer vaccine to be available in market this month at Rs 2000 for two doses - Video
|
Overview
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said. The first indigenous human papillomavirus (HPV) vaccine was launched by Union Home Minister Amit Shah on January 24 in the presence of Serum Institute of India (SII) CEO Adar Poonawalla and its Director of Government and Regulatory Affairs Prakash Kumar Singh.
According to an official source, Singh has written a letter to the Union Health Ministry mentioning that the price of its HPV vaccine for the private market will be Rs 2,000 per vial of two doses which is much lower than other available HPV vaccines.
For more details, check out the link given below:
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751